Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells
Background: Current therapeutic strategies for advanced prostate cancer (PCa) are largely ineffective. Because aberrant DNA methylation associated with inappropriate gene-silencing is a common feature of PCa, DNA methylation inhibitors might constitute an alternative therapy. In this study we aimed...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2014
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.22/3844 |
País: | Portugal |
Oai: | oai:recipp.ipp.pt:10400.22/3844 |